Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis

Background and objectives: Following the discovery of new drugs, physicians and pharmaceutical companies have become interested in examining patients’ mortality and morbidity rates. In this respect, the effects of methotrexate (MTX)+etanercept/infliximab (ETA/INF) therapy on the survival of rheumato...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pragmat Obs Res
Hlavní autoři: Akhlaghi, Saeed, Sahebari, Maryam, Mahmoodi, Mahmoud, Yaseri, Mehdi, Mansournia, Mohammad Ali, Zeraati, Hojjat
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503221/
https://ncbi.nlm.nih.gov/pubmed/31118865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/POR.S194408
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky